The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications

BJR|open · Published 2023-12-12 · DOI 10.1093/bjro/tzae040

Authors being retrieved — see the publisher record. https://doi.org/10.1093/bjro/tzae040

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2023

Related articles

State of the art: radiomics and radiomics-related artificial intelligence on the road to clinical translation · BJR|open · 2023 · Same journal
The CT knee arthrogram revisited · BJR|open · 2023 · Same journal
Cementoplasty to cryoablation: review and current status · BJR|open · 2023 · Same journal
Image Quality and Radiation Dose Comparison for Abdominopelvic CT Studies Performed Using Photon-counting CT and Dual-energy CT: a Clinical Study · BJR|open · 2025 · Same journal
EcoRad: sustainable radiology and the ecology of economics · BJR|open · 2024 · Same journal
Radiotherapy dose escalation using pre-treatment diffusion-weighted imaging in locally advanced rectal cancer: a planning study · BJR|open · 2023 · Same journal
Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods study · BJR|open · 2024 · Same journal
Assessment of heart-substructures auto-contouring accuracy for application in heart-sparing radiotherapy for lung cancer · BJR|open · 2023 · Same journal
Exploring the therapeutic potential of localized alpha irradiation for cancer: from DNA damage to immune activation · BJR|open · 2024 · Same journal
Radiological extranodal extension in head and neck cancers: current evidence and challenges in imaging detection and prognostic impact · BJR|open · 2024 · Same journal